These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36410088)

  • 21. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
    Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
    Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemma.
    Zengin N; Kars A; Sungur A; Zengin NI; Hayran M; Tekuzman G; Kansu E; Ruacan S; Firat D
    Am J Hematol; 1999 Dec; 62(4):208-11. PubMed ID: 10589075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
    Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
    Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
    Capalbo S; Callea V; Musolino C; Guglielmo P; D'Arena G; Fragasso A; Battista C; Giustolisi R; Brugiatelli M; Liso V
    Int J Hematol; 2004 May; 79(4):354-7. PubMed ID: 15218964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of HER-2/neu overexpression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia.
    Potti A; Ganti AK; Koch M; Mehdi SA; Levitt R
    Lung Cancer; 2001 Nov; 34(2):227-32. PubMed ID: 11679181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
    Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
    Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.
    Kubica AW; Rose PS; Weaver AL; Brewer JD
    Mayo Clin Proc; 2011 Aug; 86(8):738-43. PubMed ID: 21803956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of lymphohaematopoietic malignancies in a petrochemical industry cohort: 1983-94 follow up.
    Huebner WW; Chen VW; Friedlander BR; Wu XC; Jorgensen G; Bhojani FA; Friedmann CH; Schmidt BA; Sales EA; Joy JA; Correa CN
    Occup Environ Med; 2000 Sep; 57(9):605-14. PubMed ID: 10935941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia and secondary hematological malignancies: A nation-wide cancer registry study.
    Lenartova A; Johannesen TB; Tjønnfjord GE
    Eur J Haematol; 2020 Jun; 104(6):546-553. PubMed ID: 32058605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic characterization and multivariate survival analysis of chronic lymphocytic leukemia in Taiwan.
    Chen PM; Lin SH; Fan SF; Chiou TJ; Hsieh RK; Yu IT; Liu JH
    Acta Haematol; 1997; 97(4):196-204. PubMed ID: 9158661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
    Hallek M; Langenmayer I; Nerl C; Knauf W; Dietzfelbinger H; Adorf D; Ostwald M; Busch R; Kuhn-Hallek I; Thiel E; Emmerich B
    Blood; 1999 Mar; 93(5):1732-7. PubMed ID: 10029603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.
    Molica S; Levato D; Dattilo A
    Haematologica; 1999 Dec; 84(12):1094-9. PubMed ID: 10586211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
    Pulte D; Redaniel MT; Bird J; Jeffreys M
    Eur J Haematol; 2015 Jun; 94(6):540-5. PubMed ID: 25315799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia.
    Wang WT; Zhu HY; Wu YJ; Xia Y; Wu JZ; Wu W; Liang JH; Wang L; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):449-457. PubMed ID: 29299750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
    Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
    Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
    Bulian P; Tarnani M; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; Deaglio S; D'Arena G; Efremov D; Marasca R; Lauria F; Gattei V; Gaidano G; Laurenti L
    Hematol Oncol; 2011 Jun; 29(2):91-9. PubMed ID: 20669154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.
    Wierda WG; O'Brien S; Wang X; Faderl S; Ferrajoli A; Do KA; Cortes J; Thomas D; Garcia-Manero G; Koller C; Beran M; Giles F; Ravandi F; Lerner S; Kantarjian H; Keating M
    Blood; 2007 Jun; 109(11):4679-85. PubMed ID: 17299097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and outcome of familial chronic lymphocytic leukemia.
    Mauro FR; Giammartini E; Gentile M; Sperduti I; Valle V; Pizzuti A; Guarini A; Giannarelli D; Foà R
    Haematologica; 2006 Aug; 91(8):1117-20. PubMed ID: 16885053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.